British journal of clinical pharmacology

Keyphrases

Publications

volume 90, number 8, 2024

Obreniokibo Ibifubara Amiesimaka, Samuel S Allemann, Rhiannon Braund, Michael Schultz, Kristina Aluzaite
Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis. British journal of clinical pharmacology 90 (8) (2024)
Gideon Stitt, Philip C Spinella, Grant V Bochicchio, Ian Roberts, Kevin James Downes, Athena F Zuppa
Population pharmacokinetic modelling and simulation of tranexamic acid in adult trauma patients. British journal of clinical pharmacology 90 (8) (2024)
Sathya Narayanan, Alexander Yuile, Bharat Venkatesh, Matthew McKay, Malinda Itchins, Nick Pavlakis, Helen Wheeler, Lauren Gray, Joe Wei, Samuel Miller, Brendan Kirwin, Mark P Molloy, Stephen Clarke
Therapeutic drug monitoring of osimertinib in EGFR mutant non-small cell lung cancer by dried blood spot and plasma collection: A pilot study. British journal of clinical pharmacology 90 (8) (2024)
Kaizheng Chen, Yaming Xie, Songyuan Chi, Dandan Chen, Guo Ran, Xia Shen
Effects of intraoperative low-dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double-blind, placebo-controlled study. British journal of clinical pharmacology 90 (8) (2024)
Agathe Molimard, Frantz Foissac, Naïm Bouazza, Inès Gana, Sihem Benaboud, Léo Froelicher, Déborah Hirt, Saïk Urien, Isabelle Desguerre, Jean Marc Treluyer, Nicole Chemaly, Rima Nabbout
Optimization of vigabatrin dosage in children with epileptic spasms: A population pharmacokinetic approach. British journal of clinical pharmacology 90 (8) (2024)
Claire Emson, Joseph K Han, Claire Hopkins, Sara Asimus, Jennifer A Cann, David Chain, Yuling Wu, Yasa Reddy, Christopher McCrae, David Cohen, James L Kreindler, Viktoria Werkström, Maria Jison, Martin Wagenmann, Claus Bachert
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial. British journal of clinical pharmacology 90 (8) (2024)
Philip Ambery, Grzegorz Zajac, Joachim Almquist, Susanne Prothon, Carol Astbury, Mary N Brown, Szilárd Nemes, Joselyne Nsabimana, Karl Edman, Lisa Öberg, Matti Lepistö, Goran Edenro, Inken Dillmann, Suman Mitra, Graham Belfield, Christina Keen, Tim Heise
The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial. British journal of clinical pharmacology 90 (8) (2024)
Jorie Versmissen, Job van Steenkiste, Birgit C P Koch, Laura E J Peeters
'Under pressure': The role of therapeutic drug monitoring in the treatment of hypertension. British journal of clinical pharmacology 90 (8) (2024)

volume 90, number 9, 2024

Jane Ellen Carland, David J Carland, Jonathan Brett, Sophie Lena Stocker, Darren M Roberts, Richard Osborne Day, Tracey-Lea Laba
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review. British journal of clinical pharmacology 90 (9) (2024)
Omnia Salah Heikal, Patrick F van Rheenen, Daan J Touw, Jos G W Kosterink, Marina Maurer, Jeroen V Koomen, Pierre Chelle, Paola Mian
Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models. British journal of clinical pharmacology 90 (9) (2024)
Priscila Akemi Yamamoto, Valvanera Vozmediano, Rodrigo Cristofoletti, Jinmai Jiang, Thomas D Schmittgen, Cristiane Masetto de Gaitani, Rafael Kemp, Ajith Kumar Sankarankutty, Jose Sebastião Dos Santos, Wilson Salgado Junior, Natalia Valadares De Moraes
Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population-based analysis. British journal of clinical pharmacology 90 (9) (2024)
Jane Knöchel, Vijender Panduga, Karin Nelander, Maria Heijer, Eva-Lotte Lindstedt, Hodan Ali, Malin Aurell, Helena Ödesjö, Pablo Forte, Kat Connolly, Hans Ericsson, Iain MacPhee
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam. British journal of clinical pharmacology 90 (9) (2024)
Geofrey Oteng Phutietsile, Nikoletta Fotaki, Prasad S Nishtala
Assessing the anticholinergic cognitive burden classification of putative anticholinergic drugs using drug properties. British journal of clinical pharmacology 90 (9) (2024)
Chukwunonso K Nwabufo, Jessica Luc, Allison McGeer, Jeremy Alexander Hirota, Samira Mubareka, Andrew C Doxey, Theo J Moraes
COVID-19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples. British journal of clinical pharmacology 90 (9) (2024)
Francesco Lapi, Ettore Marconi, Alessandro Rossi, Erik Lagolio, Ercole Concia, Claudio Cricelli
The use of C-reactive protein testing and antibiotic prescribing in Italy: A population-based study in primary care. British journal of clinical pharmacology 90 (9) (2024)
Juliane Rascher, Dan Cotton, Sebastian Haertter, Martina Brueckmann
Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure. British journal of clinical pharmacology 90 (9) (2024)
Christian Laveille, Eric Snoeck, Lourdes Ochoa Díaz de Monasterioguren, Javier Martínez-González, Jordi Llaudó, Lourdes Anta, Ibon Gutierro
Development of a population pharmacokinetic model for the novel long-acting injectable antipsychotic risperidone ISM®. British journal of clinical pharmacology 90 (9) (2024)
Hye Jin Son, Nam Kyung Je
Impact of narcotics information management system on inappropriate benzodiazepine receptor agonist prescriptions: A quasi-experimental analysis in South Korea. British journal of clinical pharmacology 90 (9) (2024)
Omnia Salah Heikal, Patrick F van Rheenen, Daan J Touw, Jos G W Kosterink, Marina Maurer, Jeroen V Koomen, Pierre Chelle, Paola Mian
Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models. British journal of clinical pharmacology 90 (9) (2024)
L Johnson, E Youssef, Joseph O'Shea, T Thornley, J Gallagher, M Ledwidge, Cristin Ryan
Estimating the prevalence of potential and actionable drug-gene interactions in Irish primary care: A cross-sectional study. British journal of clinical pharmacology 90 (9) (2024)
Yue-Wen Chen, Xi-Kai Lin, Chen Huang, Wei Wu, Wei-Wei Lin, Si Chen, Zong-Xing Lu, Ya-Yi You, Zhou-Jie Liu
Vancomycin trough concentration in adult patients with periprosthetic joint infection: A machine learning-based covariate model. British journal of clinical pharmacology 90 (9) (2024)
Shichao Xiao, Hang Yin, Xin Lv, Zhen Wang, Lili Jiang, Yangliu Xia, Yong Liu
Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis. British journal of clinical pharmacology 90 (9) (2024)
Priscila Akemi Yamamoto, Valvanera Vozmediano, Rodrigo Cristofoletti, Jinmai Jiang, Thomas D Schmittgen, Cristiane Masetto de Gaitani, Rafael Kemp, Ajith Kumar Sankarankutty, Jose Sebastião Dos Santos, Wilson Salgado Junior, Natalia Valadares De Moraes
Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population-based analysis. British journal of clinical pharmacology 90 (9) (2024)
Zeng-Xiang Zhao, Tian-Yi Yang, Yuan-Hui Wang, Li Zhang, Ji Li, Yu-Wen Su
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology 90 (9) (2024)
Peijue Zhang, Jieon Lee, Kairui Feng, Andrew Babiskin, Miyoung Yoon, Lanyan Fang, Liang Zhao
Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al. British journal of clinical pharmacology 90 (9) (2024)
Chukwunonso K Nwabufo, Jessica Luc, Allison McGeer, Jeremy Alexander Hirota, Samira Mubareka, Andrew C Doxey, Theo J Moraes
COVID-19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples. British journal of clinical pharmacology 90 (9) (2024)
Marion Bennie, Yared Santa-Ana-Tellez, Githa Fungie Galistiani, Julien Trehony, Johanna Despres, Laurence Sophie Jouaville, Elisabetta Poluzzi, Lucas Morin, Ingrid Schubert, Seán MacBride-Stewart, Monique Elseviers, Paola Nasuti, Katja Taxis
The prevalence of polypharmacy in older Europeans: A multi-national database study of general practitioner prescribing. British journal of clinical pharmacology 90 (9) (2024)
Daping Zhang, Zufei Zhang, Anthony Lee, Keenan Fenton, Shweta Jain, Amit Garg, Yen Lin Chia
Time-varying brentuximab vedotin pharmacokinetics and weight-based dosing in paediatric patients despite lower exposure in those aged 2 to <6 and 6-11 years. British journal of clinical pharmacology 90 (9) (2024)
Adrian Steulet, Bonniface Obura, Catriona Waitt, Eva Laker, Melanie R Nicol, Fiona V Cresswell
Clinical pharmacology considerations and drug-drug interactions with long-acting cabotegravir and rilpivirine relevant to sub-Saharan Africa. British journal of clinical pharmacology 90 (9) (2024)
L Johnson, E Youssef, Joseph O'Shea, T Thornley, J Gallagher, M Ledwidge, Cristin Ryan
Estimating the prevalence of potential and actionable drug-gene interactions in Irish primary care: A cross-sectional study. British journal of clinical pharmacology 90 (9) (2024)
Sheila Feitosa Ramos, Letícia Gomes do Sacramento, Rafaella Oliveira Santos de Silva, Giulyane Targino Aires-Moreno, Jonas Dos Santos Gomes, Alessandra Rezende Mesquita, Elisangela Costa Lima, Divaldo Pereira de Lyra
Moderate and serious adverse reactions to antimicrobials among hospitalized children: A systematic review. British journal of clinical pharmacology 90 (9) (2024)
Geofrey Oteng Phutietsile, Nikoletta Fotaki, Prasad S Nishtala
Assessing the anticholinergic cognitive burden classification of putative anticholinergic drugs using drug properties. British journal of clinical pharmacology 90 (9) (2024)
Christian Laveille, Eric Snoeck, Lourdes Ochoa Díaz de Monasterioguren, Javier Martínez-González, Jordi Llaudó, Lourdes Anta, Ibon Gutierro
Development of a population pharmacokinetic model for the novel long-acting injectable antipsychotic risperidone ISM®. British journal of clinical pharmacology 90 (9) (2024)
Zeng-Xiang Zhao, Tian-Yi Yang, Yuan-Hui Wang, Li Zhang, Ji Li, Yu-Wen Su
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology 90 (9) (2024)
Malcolm Bjørn Gillies, Kendal Chidwick, Chrianna Bharat, Ximena Camacho, David Currow, Natasa Gisev, Louisa Degenhardt, Sallie-Anne Pearson
Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014-2020)-A population-based descriptive cohort study. British journal of clinical pharmacology 90 (9) (2024)
Peijue Zhang, Jieon Lee, Kairui Feng, Andrew Babiskin, Miyoung Yoon, Lanyan Fang, Liang Zhao
Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al. British journal of clinical pharmacology 90 (9) (2024)
Negin Soroush, Albert-Jan Aarnoudse, Maryam Kavousi, Jan A Kors, M Arfan Ikram, Bruno H Stricker, Fariba Ahmadizar
The NOS1AP gene rs10494366 common genetic variant does not modify the risk of sudden cardiac death in users of digoxin. British journal of clinical pharmacology 90 (9) (2024)
Negin Soroush, Albert-Jan Aarnoudse, Maryam Kavousi, Jan A Kors, M Arfan Ikram, Bruno H Stricker, Fariba Ahmadizar
The NOS1AP gene rs10494366 common genetic variant does not modify the risk of sudden cardiac death in users of digoxin. British journal of clinical pharmacology 90 (9) (2024)
Malcolm Bjørn Gillies, Kendal Chidwick, Chrianna Bharat, Ximena Camacho, David Currow, Natasa Gisev, Louisa Degenhardt, Sallie-Anne Pearson
Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014-2020)-A population-based descriptive cohort study. British journal of clinical pharmacology 90 (9) (2024)
Marion Bennie, Yared Santa-Ana-Tellez, Githa Fungie Galistiani, Julien Trehony, Johanna Despres, Laurence Sophie Jouaville, Elisabetta Poluzzi, Lucas Morin, Ingrid Schubert, Seán MacBride-Stewart, Monique Elseviers, Paola Nasuti, Katja Taxis
The prevalence of polypharmacy in older Europeans: A multi-national database study of general practitioner prescribing. British journal of clinical pharmacology 90 (9) (2024)
Sheila Feitosa Ramos, Letícia Gomes do Sacramento, Rafaella Oliveira Santos de Silva, Giulyane Targino Aires-Moreno, Jonas Dos Santos Gomes, Alessandra Rezende Mesquita, Elisangela Costa Lima, Divaldo Pereira de Lyra
Moderate and serious adverse reactions to antimicrobials among hospitalized children: A systematic review. British journal of clinical pharmacology 90 (9) (2024)
Adrian Steulet, Bonniface Obura, Catriona Waitt, Eva Laker, Melanie R Nicol, Fiona V Cresswell
Clinical pharmacology considerations and drug-drug interactions with long-acting cabotegravir and rilpivirine relevant to sub-Saharan Africa. British journal of clinical pharmacology 90 (9) (2024)
Jane Knöchel, Vijender Panduga, Karin Nelander, Maria Heijer, Eva-Lotte Lindstedt, Hodan Ali, Malin Aurell, Helena Ödesjö, Pablo Forte, Kat Connolly, Hans Ericsson, Iain MacPhee
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam. British journal of clinical pharmacology 90 (9) (2024)
Shichao Xiao, Hang Yin, Xin Lv, Zhen Wang, Lili Jiang, Yangliu Xia, Yong Liu
Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis. British journal of clinical pharmacology 90 (9) (2024)
Yue-Wen Chen, Xi-Kai Lin, Chen Huang, Wei Wu, Wei-Wei Lin, Si Chen, Zong-Xing Lu, Ya-Yi You, Zhou-Jie Liu
Vancomycin trough concentration in adult patients with periprosthetic joint infection: A machine learning-based covariate model. British journal of clinical pharmacology 90 (9) (2024)
Francesco Lapi, Ettore Marconi, Alessandro Rossi, Erik Lagolio, Ercole Concia, Claudio Cricelli
The use of C-reactive protein testing and antibiotic prescribing in Italy: A population-based study in primary care. British journal of clinical pharmacology 90 (9) (2024)
Jane Ellen Carland, David J Carland, Jonathan Brett, Sophie Lena Stocker, Darren M Roberts, Richard Osborne Day, Tracey-Lea Laba
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review. British journal of clinical pharmacology 90 (9) (2024)
Daping Zhang, Zufei Zhang, Anthony Lee, Keenan Fenton, Shweta Jain, Amit Garg, Yen Lin Chia
Time-varying brentuximab vedotin pharmacokinetics and weight-based dosing in paediatric patients despite lower exposure in those aged 2 to <6 and 6-11 years. British journal of clinical pharmacology 90 (9) (2024)
Hye Jin Son, Nam Kyung Je
Impact of narcotics information management system on inappropriate benzodiazepine receptor agonist prescriptions: A quasi-experimental analysis in South Korea. British journal of clinical pharmacology 90 (9) (2024)
Juliane Rascher, Dan Cotton, Sebastian Haertter, Martina Brueckmann
Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure. British journal of clinical pharmacology 90 (9) (2024)